HTR2B and schizophrenia: The studies could be useful for designing selective agonists/antagonists for various serotonin receptors (5HT1A, 5HT2A, 5HT2B, 5HT2C, and 5HT7) involved in detrimental disorders such as addiction and schizophrenia in the future.